2nd Quarter - Amendment
ARDELYX, INC. for ARDELYX, INC.
Firm
Client
Income
—
Expenses
$500,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 15, 2026 | $500,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jul 16, 2026 | $500,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Access to innovative medications for people with kidney failure; reimbursement; drug pricing; most favored nation drug pricing; Medicare kidney care access and payment issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA JOLIVETTE | — |
| ZACHARY KRIBS | — |
| MATTHEW LASH | — |
| PAUL PEREIRA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.